REQUEST A DEMO
Total
USD $0.00
Search more companies

GeneReach Biotechnology Corp. (Taiwan, China)

Main Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: GeneReach Biotechnology Corp. Profile Updated: May 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

GeneReach Biotechnology Corp. (stock code: 4171) is principally engaged in R & D production and sales of nucleic acid detection equipment and nucleic acid extraction reagents. The company was established in November 12, 2004 and head office is located in Taichung City.

Headquarters
No.19,Keyuan 2Nd Road, Science Park
Taichung City; Taichung City;

Contact Details: Purchase the GeneReach Biotechnology Corp. report to view the information.

Website: http://www.genereach.com

Basic Information
Total Employees:
Purchase the GeneReach Biotechnology Corp. report to view the information.
Outstanding Shares:
Purchase the GeneReach Biotechnology Corp. report to view the information.
Financial Auditors:
Purchase the GeneReach Biotechnology Corp. report to view the information.
Incorporation Date:
November 12, 2004
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Executive Committee
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
4.9%
Purchase this report to view the information.
4.02%
Purchase this report to view the information.
0.03%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Genereach Usa,Inc (United States)
100%
金瑞鴻捷(廈門)生物科技有限公司 (China)
59.95%
Company Performance
Financial values in the chart are available after GeneReach Biotechnology Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-27.26%
Total operating revenue
-25.41%
Operating profit (EBIT)
1.05%
EBITDA
14.51%
Net Profit (Loss) for the Period
31.04%
Total assets
-19.58%
Total equity
-14.75%
Operating Profit Margin (ROS)
-27.97%
Net Profit Margin
3.62%
Return on Equity (ROE)
1.72%
Debt to Equity Ratio
33.64%
Quick Ratio
0.37%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?